NEUROCYCLE THERAPEUTICS INC has a total of 15 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are FURIEX PHARMACEUTICALS INC, SPERO TRINEM INC and CGENETECH SUZHOU CHINA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 | |
#9 | Taiwan | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Toczko Matthew | 13 |
#2 | Hubbs Jed | 13 |
#3 | He Yunliang | 1 |
#4 | Li Zheng Jane | 1 |
#5 | Ning Yuxi | 1 |
#6 | Liu Xianglei | 1 |
#7 | Jed Hubbs | 1 |
#8 | Matthew Toczko | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021081357A1 | Treatment of epileptic conditions with gabaa receptor modulators | |
WO2021081147A1 | Gabaa positive allosteric modulator compounds, methods of making, and uses thereof | |
WO2020191047A1 | Use of gabaa receptor modulators for treatment of pain | |
WO2019226820A1 | Gabaa positive allosteric modulator compounds for treatment of itch and/ or dermatitis | |
SG11202010220QA | Gabaa positive allosteric modulator compounds, methods of making, and uses thereof |